Call 408.493.1800 | Fax 408.493.1801 | Toll Free 800.891.9699 (US Only) | Email: [email protected]


Dihomo-γ-Linolenic Acid

An anti-atherogenic agent
Catalog #: B2751
SKU-Size Size Price Qty
B2751-10 10 mg
B2751-50 50 mg
More Sizes Get Quote

Product Details

Alternate Name DGLA; 8Z,11Z,14Z-eicosatrienoic acid
Peptide Sequence N/A
Appearance Liquid
Formulation A solution in ethanol
CAS # 1783-84-2
Molecular Formula C₂₀H₃₄O₂
Molecular Weight 306.5
Purity ≥98%
InChi InChI=1S/C20H34O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20(21)22/h6-7,9-10,12-13H,2-5,8,11,14-19H2,1H3,(H,21,22)/b7-6-,10-9-,13-12-
PubChem CID 5280581
MDL Number MFCD00065721
Handling Do not take internally. Wear gloves and mask when handling the product! Avoid contact by all modes of exposure.
Storage Conditions -20ºC
Shipping Conditions Gel Pack
USAGE For Research Use Only! Not For Use in Humans.


Dihomo-γ-Linolenic Acid (DGLA, 20:3), an elongation product of γ-linolenic acid (18:3), is rapidly metabolized by fatty acid desaturases to produce arachidonic acid (20:4). DGLA is metabolized through the cyclooxygenase pathway to produce 1-series prostaglandins, including PGE1. DGLA also inhibits several key cellular processes associated with atherosclerosis.

Why buy BioVision Products?
Global Presence
Technical Support
BioVision aims to provide our customers innovative tools for accelerating drug discovery and biological research. BioVision offers >8,000 products including the most comprehensive array of assay kits for key targets in Metabolic pathways.
BioVision is committed to providing the highest quality products at a competitive price.
We have a broad network of global distributors who are ready to address your research needs and ensure fast delivery.
Our highly trained Technical Support team provides comprehensive product support and is dedicated to resolving your issues quickly and efficiently.